Boston Scientific Corporation Conference Call Summary Company Overview - **Company**: Boston Scientific Corporation (NYSE: BSX) - **Event**: UBS Global Healthcare Conference - **Date**: November 12, 2024 Key Points Financial Performance - **Q3 2024 Organic Revenue Growth**: 18.2% [3] - **Adjusted Operating Margin**: 27.2% [3] - **Earnings Per Share (EPS) Growth**: 27% in Q3 2024 [3] - **2024 Guidance**: Raised to 15% organic revenue growth, with an expected operating margin expansion of 70 basis points to approximately 27% [3] - **2024 Adjusted EPS Growth Guidance**: 20% to 21% [3] Growth Catalysts - **Key Growth Drivers**: WATCHMAN and Electrophysiology (EP) business, particularly FARAPULSE, which is transforming the atrial fibrillation (AF) ablation market [4] - **Market Position**: Company aims to be the highest-performing large-cap med tech company with broad-based growth across all business segments [4] FARAPULSE and AF Ablation Market - **Adoption Rate**: Accelerated adoption of electroporation technology with FARAPULSE, exceeding initial expectations [7] - **Market Share**: Tracking ahead of the projected 40% to 60% of ablation procedures being performed with PFA by 2026 [6] - **User Experience**: Positive feedback on ease of use and safety, leading to rapid rebooking of patients [8] - **Competitive Landscape**: Company maintains a first-mover advantage in the PFA market, with ongoing innovation to fend off competition [10][12] WATCHMAN Device - **Clinical Trial**: OPTION trial comparing WATCHMAN to oral anticoagulants for stroke prevention in post-AFib ablation patients [24] - **Market Potential**: Positive trial results could expand the indicated patient population by 1 million to 2 million, increasing the market size from $1.7 billion to $6 billion by 2030 [25] - **Indication Expansion**: Anticipated submission for indication expansion in the second half of 2025, with potential to increase the indicated patient pool from 4 million to 18 million by 2030 [30] International Market Opportunities - **Expansion into Asia**: Launching in China and Japan in 2025, with both markets representing a multibillion-dollar opportunity [38] - **Market Dynamics**: Each market has unique characteristics, and the company is well-positioned to capture share due to strong supply chain and manufacturing capabilities [41] Innovation and Product Development - **New Products**: Introduction of FARAWAVE mapping system and continued innovation in PFA technology [23][54] - **Future Trials**: Plans for additional trials like ADVANTAGE and AVANT GUARD to expand indications and enhance product offerings [54][48] Competitive Moat - **Market Share**: Company holds over 90% market share for WATCHMAN, with ongoing innovation to maintain leadership [31][32] - **Clinical Evidence**: Strong focus on generating clinical evidence to support product efficacy and safety [33] Capacity and Treatment Trends - **Capacity Management**: Hospitals are adapting by increasing the number of electrophysiologists and cath labs to meet growing demand for AF ablation procedures [51] - **Ambulatory Surgery Centers**: Potential future growth in treating patients in outpatient settings [52] Summary Boston Scientific is experiencing robust growth driven by its innovative products in the electrophysiology and left atrial appendage closure markets. The company is well-positioned for future expansion, particularly in international markets, and is focused on maintaining its competitive edge through continuous innovation and clinical evidence generation.

FedEx Corporation (NYSE:FDX) Baird Global Industrial Conference November 12, 2024 Industry/Company * **Industry**: Transportation and logistics * **Company**: FedEx Corporation (NYSE:FDX) Core Points and Arguments 1. **DRIVE Program**: FedEx's DRIVE program aims to achieve $2.2 billion in savings by fiscal year 2025, following $1.8 billion in savings in fiscal year 2024. The program focuses on cost-cutting initiatives and operational improvements across the company. 2. **Network 2.0**: This initiative involves optimizing the company's network by improving facilities, personnel, and technology. It is expected to be completed by the end of fiscal year 2027. 3. **Peak Season Preparedness**: FedEx is well-prepared for the peak season, with adequate staffing and capacity to meet customer demand. 4. **Tariffs and Taxes**: FedEx supports free trade and is prepared to adapt to any changes in tariffs or taxes. The company has a strong presence in 220 countries and can adapt to changes in demand. 5. **Pricing Strategy**: FedEx has implemented peak pricing surcharges and is encouraged by its ability to pass along costs to customers. The pricing environment remains rational and competitive. 6. **Postal Service Contract Expiration**: FedEx is prepared for the expiration of its Postal Service contract, which will result in a loss of revenue. The company has taken immediate action to mitigate the impact and is working to adapt its network to the change. 7. **Product Mix Shift**: FedEx has seen a shift in product mix towards deferred services, which has put pressure on earnings and margins. The company is focused on improving yields and managing costs. 8. **European Operations**: FedEx is working to improve profitability in Europe through service improvements and operational efficiencies. The company has implemented new leadership and is focused on improving service quality. 9. **Tricolor Program**: This program involves redesigning the company's network to optimize asset utilization and improve efficiency. It includes three networks: purple (Express), white (e-commerce deferred), and orange (priority freight). 10. **Freight Business**: FedEx is conducting a strategic review of its freight business and expects to announce the outcome by the end of the year. 11. **Capital Allocation**: FedEx is focused on investing capital in areas with the highest return on invested capital (ROIC), such as network modernization and hub modernization. The company has reduced capital expenditures and is committed to returning capital to shareholders through share repurchases and dividends. Other Important Points * FedEx has implemented a One FedEx structure, bringing together its Ground and Express companies to create more opportunities for collaboration and efficiency. * The company has a strong focus on talent development and cross-functional collaboration. * FedEx is committed to improving its environmental sustainability and has set ambitious goals for reducing emissions and waste.

Union Pacific Corporation Conference Call Summary Company Overview - **Company**: Union Pacific Corporation (NYSE: UNP) - **Participants**: Jennifer Hamann (CFO), Rahul Jalali (CIO), Garrett Holland (Robert W. Baird & Co.) Key Points Financial Performance - **Q3 Performance**: Achieved 11% growth in operating income and 10% growth in earnings per share (EPS) [5][10] - **Volume Growth**: Reported a 6% increase in volume, primarily driven by a 33% increase in international intermodal volumes [7][12] - **Revenue Growth**: Freight revenue growth, excluding fuel, was 5% [7] - **Operating Ratio**: Improved by 310 basis points to 60.3%, marking the third consecutive quarter of industry-leading performance [10][11] Strategic Focus - **Core Strategy**: Emphasizes safety, service, and operational excellence as fundamental components of the business [6] - **Service Improvement**: Noted improvements in freight car dwell and freight velocity, indicating enhanced service delivery [13][14] - **Workforce Productivity**: Achieved all-time best productivity metrics in September and Q3 [14] Growth Opportunities - **Revenue Pipeline**: Identified a pipeline of $1.6 billion in revenue opportunities from approximately 200 track construction projects [19] - **Market Segments**: Focus on truckload conversion, access to Mexico, petrochemicals, and grain products as key growth areas [20][22][23] - **Long-term Contracts**: 75% of long-term contracts have been repriced since 2022, with expectations for further adjustments [25][26] Pricing Strategy - **Pricing Dynamics**: Core pricing continues to exceed inflation, with expectations for pricing to become accretive to margins starting in 2025 [30][52] - **Customer Engagement**: Emphasizes the importance of providing value to customers to facilitate pricing discussions and increase market share [52] Technology and Innovation - **Tech Investments**: Implemented advanced technology systems, including AI and machine learning, to enhance operational efficiency [42][44] - **Customer Visibility**: Launched a pilot program for a visibility solution called "Customer Vision" to improve customer experience [48][49] Market Outlook - **2025 Guidance**: Anticipates moderate growth in volumes and revenue, with a focus on maintaining industry leadership in operating ratio [29][31][61] - **Economic Indicators**: Current outlook suggests incremental growth rather than dramatic shifts in the market [61] Capital Allocation - **Shareholder Returns**: Plans to return $4 billion to $5 billion in shares to shareholders annually over the next three years, alongside consistent annual dividend increases [32] Regulatory Environment - **Regulatory Impact**: Acknowledges the potential for regulatory changes to positively impact the business, though specifics remain uncertain [39] Conclusion - **Overall Sentiment**: The company expresses optimism about future growth and the execution of its strategic initiatives, positioning itself well for sustained performance in the industry [33][66]

Johnson & Johnson (NYSE:JNJ) Guggenheim Global Healthcare Conference November 12, 2024 10:30 AM ET Company Participants Biljana Naumovic - Worldwide VP, Global Commercial Strategy, Oncology Mark Wildgust - VP, Global Medical Affairs Oncology Conference Call Participants Vamil Divan - Guggenheim Securities Edouard Mullarky - Guggenheim Securities Vamil Divan All right. I think we're ready to get started. Thanks, everyone, again, for joining us at the Guggenheim Inaugural Healthcare Innovation Conference this ...

Elevance Health, Inc. (NYSE:ELV) UBS Global Healthcare Conference November 12, 2024 10:15 AM ET Company Participants Mark Kaye - Executive VP & CFO Conference Call Participants A.J. Rice - UBS A.J. Rice I think we'll go ahead and kick off today. I'm A.J. Rice, the health care services analyst at UBS. Thanks, everybody, for coming out to our conference this year. We're very pleased to have to kick off our session Elevance Health and principal speaker is going to be Mark Kaye, Chief Financial Officer and Exec ...

CRISPR Therapeutics AG (NASDAQ:CRSP) Guggenheim Inaugural Healthcare Innovation Conference November 12, 2024 2:00 PM ET Company Participants Samarth Kulkarni - CEO and Chairman Conference Call Participants Debjit Chattopadhyay - Guggenheim Partners Debjit Chattopadhyay Good afternoon and thank you for joining us at Guggenheim's Inaugural Healthcare Innovations Conference. I am Debjit and one of the therapeutic analysts here. And joining me today is Samarth Kulkarni, CEO and Chairman of CRISPR Therapeutics. ...

Summary of Key Points from the Conference Call Industry or Company Involved - The discussion primarily revolves around the implications of Donald Trump's re-election on various sectors, including the economy, trade, and climate change policies. Core Points and Arguments 1. **Market Reactions to Trump's Re-election** - Stock and corporate-bond markets are responding positively to Trump's re-election, with the S&P 500 hitting record highs and the Dow Jones Industrial Average closing above 44,000 for the first time. Tesla's stock valuation surpassed $1 trillion again, and Bitcoin surged by 30% to over $90,000 [29][30][39] 2. **Inflation and Interest Rates** - America's annual inflation rate increased to 2.6% in October, up from 2.4% in September. The Federal Reserve is expected to cut interest rates again, following a recent reduction to a range of 4.5% to 4.75% [30] 3. **China's Economic Stimulus** - China's latest stimulus package of 10 trillion yuan ($1.4 trillion) disappointed investors, failing to significantly boost household spending. The package aims to support distressed local authorities [32][101] 4. **SoftBank's Performance** - SoftBank reported a quarterly net profit of ¥1.2 trillion ($7.8 billion), driven by strong performance from its Vision Funds and a push into artificial intelligence [33] 5. **Siemens Energy's Recovery** - Siemens Energy reported a net profit of €1.3 billion ($1.4 billion), recovering from a €4.6 billion loss the previous year, although the outlook for renewable energy remains uncertain under a second Trump presidency [35] 6. **Volkswagen's Investment in Rivian** - Volkswagen increased its investment in Rivian from $5 billion to $5.8 billion to develop electric vehicle technology, with the first VW cars using Rivian's technology expected by 2027 [36] 7. **Just Eat Takeaway's Sale of Grubhub** - Just Eat Takeaway decided to sell Grubhub for $650 million, a significant loss compared to the $7.3 billion paid in 2021 [37] 8. **Tencent's Profit Growth** - Tencent's quarterly profit rose by 47% year-on-year to 53.2 billion yuan ($7.4 billion), aided by the release of the "Dungeon & Fighter Mobile" game in China [38] 9. **Netflix's Subscription Growth** - Netflix reported that 50% of new subscribers are opting for its ad-supported subscription, with 70 million monthly active users on this plan, up from 40 million six months ago [39] 10. **Climate Change and Technology** - The re-election of Trump is expected to negatively impact climate-related policies in the U.S., but the trend towards cheaper renewable energy technologies continues, providing hope for emissions reduction [81][82][87] 11. **Global Trade and Tariffs** - Trump's administration is likely to impose tariffs of up to 60% on China and 10-20% on other countries, which could harm global trade and economic growth [56][62] 12. **Bangladesh's Political Stability** - Following the overthrow of Sheikh Hasina, interim leader Muhammad Yunus has stabilized the economy, but faces challenges including food inflation and demands for elections [108][109] Other Important but Possibly Overlooked Content - The potential for a global trade war under Trump's administration could have severe implications for developing countries, particularly those reliant on exports to the U.S. [60][63] - The need for rich countries to assist poorer nations in transitioning to renewable energy is emphasized, as many lack the capital to invest in clean technologies [88][90] - The importance of establishing a clear plan for governance in Bangladesh to avoid a return to political instability is highlighted [115]

****** FRIDAY, NOVEMBER 15, 2024 ~ VOL. CCLXXXIV NO. 117 WSJ.com HHHH $5.00 How Beijing Took Over Banking Hub INSIDE DJIA 43750.86 g 207.33 0.47% NASDAQ 19107.65 g 0.6% STOXX 600 507.03 À 1.1% 10-YR. TREAS. À 6/32 , yield 4.425% OIL $68.70 À $0.27 GOLD $2,568.20 g $12.60 EURO $1.0531 YEN 156.27 World's Largest Coral Found Off Solomon Islands SEASCAPE: Divers swim over the newly discovered coral, believed to be the world's largest, in the Pacific Ocean. The coral, MANU SAN FELIX/NATIONAL GEOGRAPHIC PRISTINE ...

Commanders come up short in 26-18 loss to Eagles. D1 RiCky CARioTi/The WAShingTon PoST Sen. John Cornyn (r-Texas) said he would like to have access to the House ethics Committee's findings on matt Gaetz. Prices may vary in areas outside metABCD ropolitan Washington. ESU V1 V2 V3 V4 | --- | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

"All the News That's Fit to Print' VOL. CLXXIV .... No. 60,339 FRIDAY, NOVEMBER 15, 2 THE WEATHER Today, turning out partly sunny, in- reasingly windy, high 58. Tonight, mostly clear, windy, low 45. Tomor- row, partly to mostly sunny, windy, Weather map, Page B12 $4.00 Staff members cleaned out the office of Representative Matt Gaetz, who resigned after being nominated to be the attorney general. NEWS ANALYSIS Trump's Picks To the Senate A Warning to Confirm Or Be Elbowed Aside By KATIE ROGERS WASHINGTON — ...